NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

NEPHROS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$3.68+0.03 (+0.82%)

Close on Oct 19, 2026

Market cap: $40.89M
P/E (TTM): 23.0
Dividend yield: –

NEPHROS INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	19	14	14	9.98	10	8.56	10	5.69	3.81	2.32	1.94	1.75	1.74	1.81	2.21	2.94	–
Cost of Revenue	7.16	5.44	5.83	5.24	4.58	3.65	4.25	2.48	1.52	1.03	0.88	0.55	0.90	0.74	1.35	1.82	–
Gross Profit	12	8.72	8.41	4.73	5.63	4.91	6.08	3.20	2.29	1.29	1.06	1.20	0.84	1.07	0.87	1.12	–
Research & Development	1.34	0.91	0.87	1.26	1.50	2.76	3.09	1.54	1.00	1.08	0.83	0.78	0.87	0.63	0.45	0.36	–
Selling, General & Admin	9.00	7.68	8.91	7.59	7.20	6.47	6.12	4.52	3.30	2.85	3.44	2.87	3.07	3.62	2.64	2.52	–
Operating Expenses	10	8.72	10.00	9.07	8.89	9.19	9.24	6.22	4.52	4.16	4.48	3.87	4.16	4.40	3.18	3.01	–
Operating Income	1.15	0.01	-1.59	-4.34	-3.25	-4.28	-3.16	-3.02	-2.23	-2.87	-3.42	-2.67	-3.32	-3.33	-2.31	-1.89	–
Interest Expense	0.00	0.00	0.00	0.02	0.04	0.11	0.20	0.17	0.30	0.17	0.04	0.48	0.35	0	0.01	0.02	–
Interest & Investment Income	0.14	0.09	0.06	0.01	0.01	0.01	–	0.00	0.00	0.01	–	–	0	0.00	0.00	0.00	–
Other Non-Operating Income	0.06	0.08	0.02	0.06	0.47	-0.25	-0.05	-0.04	-0.07	0.00	0.04	0.06	-0.03	0.01	0.00	0.02	–
Asset Impairment Charges	0	0	0	1.40	0	0	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	0.01	–	–	–	–	–	-0.01	–	–	–	0	0.00	0.06	–	–	–
Pretax Income	1.21	0.09	-1.58	–	–	-4.53	-3.40	-3.42	-2.60	-3.03	–	–	–	–	–	–	–
Income Tax Expense	0.01	0.02	0	0	0	–	-0.23	-0.09	-1.79	–	–	–	–	–	–	–	–
Income from Continuing Operations	1.19	0.07	-1.58	-4.28	-2.78	–	–	–	–	–	–	–	–	–	–	–	–
Income from Discontinued Operations	–	–	–	-2.83	-1.08	–	–	–	–	–	–	–	–	–	–	–	–
Net Income incl. Noncontrolling Interests	–	–	-1.58	-7.11	-3.87	–	-3.18	-3.33	-0.81	-3.03	-3.09	–	–	–	–	–	–
Minority Interest in Earnings	–	–	–	0.28	0.24	–	0.24	0.08	–	–	–	–	–	–	–	–	–
Net Income	1.19	0.07	-1.58	–	-3.87	-4.53	-3.18	-3.40	-0.81	-3.03	-3.09	-7.37	1.32	-6.62	-7.00	3.88	-12
Net Income to Common	–	–	-1.58	-7.38	-4.11	-4.77	-3.42	–	–	-3.03	-3.16	-7.37	1.32	–	–	3.88	–
EPS (Basic)(per share)	0.11	0.01	-0.15	-0.73	-0.41	-0.52	-0.45	-0.50	-0.18	-0.54	-0.81	-2.79	0.72	-5.31	-7.29	16.74	-56.88
EPS (Diluted)(per share)	0.11	0.01	-0.15	-0.73	-0.41	-0.52	-0.45	-0.50	-0.18	-0.54	-0.81	-2.79	-1.62	-5.31	-7.29	16.74	-56.88
Shares Outstanding (Basic, Weighted)(shares)	11	11	10	10	10	9.08	7.54	6.85	5.88	5.40	3.86	2.65	1.74	1.25	0.96	0.23	–
Shares Outstanding (Diluted, Weighted)(shares)	11	11	10	10	10	9.08	7.54	6.85	5.88	5.40	3.86	2.65	2.31	1.25	0.96	0.23	–
EBITDA	1.29	0.14	-1.38	-4.12	-3.06	-4.08	-2.97	-2.85	-2.01	-2.64	-3.42	-2.66	-3.31	-3.32	-2.22	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 61.3%
Operating margin: 7.9%
Net margin: 8.4%
Return on equity, FY2025: –

Financial strength

Current ratio: 4.07
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 140.5%

Valuation

P/E ratio: 23.0
Price to sales: 1.97
Price to book: –
Dividend yield: –